Biotech News
Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy
investors.primemedicine.com2026-05-06 14:53 EST
-- Webcast event to begin at 8:00am ET on Wednesday, November 12, 2025 -- CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that